AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2017
Sep 19, 2017
34395_dirs_2017-09-19_2bed475b-136c-4bb8-a205-e479c405566e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2017-09-19
Reporting Person: Vanston David Cecil (CHIEF FINANCIAL OFFICER)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-19 | COMMON STOCK | P | 2750 | $2.84 | Acquired | 2750 | Direct |